Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ballestar, E.
Right arrow Articles by Esteller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballestar, E.
Right arrow Articles by Esteller, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 7, 1103-1109, July 2002
© 2002 Oxford University Press


REVIEW

The impact of chromatin in human cancer: linking DNA methylation to gene silencing

Esteban Ballestar and Manel Esteller,1

Cancer Epigenetics Laboratory, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain

For decades, chromatin was considered to be an inert structure whose only role was the compacting and confining of DNA inside the eukaryotic nucleus. However, tremendous progress in this field over the last 10 years has dramatically elevated chromatin to a key position in the control of gene activity. Its role in mediating the transformation of a normal cell into a malignant state is particularly interesting. On one side of this story there is the discovery that aberrant methylation patterns in an increasing number of tumour suppressor and DNA repair genes determine carcinogenetic transformation; while on the other side, there is the existence of a series of methyl-DNA binding activities that recruit co-repressor complexes and modify the structure of the chromatin to produce a transcriptionally silenced state. Although this field has seen rapid progress in recent years, detailed mechanisms by which this machinery modifies chromatin structure to its appropriate state and the specific targeting of repressor complexes have yet to be resolved. In this review we present the models of how repressor complexes may modify chromatin structure and mediate silencing of tumour suppressor and DNA repair genes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
X. Wang, X. Wu, Z. Liang, Y. Huang, M. Fenech, and J. Xue
A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan
Mutagenesis, January 1, 2006; 21(1): 41 - 47.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. H. Ezzeldin, A. M. Lee, L. K. Mattison, and R. B. Diasio
Methylation of the DPYD Promoter: An Alternative Mechanism for Dihydropyrimidine Dehydrogenase Deficiency in Cancer Patients
Clin. Cancer Res., December 15, 2005; 11(24): 8699 - 8705.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y.-I. Kim
Nutritional Epigenetics: Impact of Folate Deficiency on DNA Methylation and Colon Cancer Susceptibility
J. Nutr., November 1, 2005; 135(11): 2703 - 2709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Peng, D. R. Hodge, S. B. Thomas, J. M. Cherry, D. J. Munroe, C. Pompeia, W. Xiao, and W. L. Farrar
Epigenetic Silencing of the Human Nucleotide Excision Repair Gene, hHR23B, in Interleukin-6-responsive Multiple Myeloma KAS-6/1 Cells
J. Biol. Chem., February 11, 2005; 280(6): 4182 - 4187.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-W. Leu, P. S. Yan, M. Fan, V. X. Jin, J. C. Liu, E. M. Curran, W. V. Welshons, S. H. Wei, R. V. Davuluri, C. Plass, et al.
Loss of Estrogen Receptor Signaling Triggers Epigenetic Silencing of Downstream Targets in Breast Cancer
Cancer Res., November 15, 2004; 64(22): 8184 - 8192.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. I. Kruman, E. Schwartz, Y. Kruman, R. G. Cutler, X. Zhu, N. H. Greig, and M. P. Mattson
Suppression of Uracil-DNA Glycosylase Induces Neuronal Apoptosis
J. Biol. Chem., October 15, 2004; 279(42): 43952 - 43960.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
K Baker, Y Zhang, C Jin, and J R Jass
Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?
J. Clin. Pathol., October 1, 2004; 57(10): 1089 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. F. Fraga, M. Herranz, J. Espada, E. Ballestar, M. F. Paz, S. Ropero, E. Erkek, O. Bozdogan, H. Peinado, A. Niveleau, et al.
A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human Tumors
Cancer Res., August 15, 2004; 64(16): 5527 - 5534.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Peinado, E. Ballestar, M. Esteller, and A. Cano
Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex
Mol. Cell. Biol., January 1, 2004; 24(1): 306 - 319.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. E. Watson, G. M. Curtin, D. J. Doolittle, and J. I. Goodman
Progressive Alterations in Global and GC-Rich DNA Methylation during Tumorigenesis
Toxicol. Sci., October 1, 2003; 75(2): 289 - 299.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Alaminos, J. Mora, N.-K. V. Cheung, A. Smith, J. Qin, L. Chen, and W. L. Gerald
Genome-wide Analysis of Gene Expression Associated with MYCN in Human Neuroblastoma
Cancer Res., August 1, 2003; 63(15): 4538 - 4546.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Zijno, C. Andreoli, P. Leopardi, F. Marcon, S. Rossi, S. Caiola, A. Verdina, R. Galati, A. Cafolla, and R. Crebelli
Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects
Carcinogenesis, June 1, 2003; 24(6): 1097 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Shi, S. H. Wei, Y.-W. Leu, F. Rahmatpanah, J. C. Liu, P. S. Yan, K. P. Nephew, and T. H.-M. Huang
Triple Analysis of the Cancer Epigenome: An Integrated Microarray System for Assessing Gene Expression, DNA Methylation, and Histone Acetylation
Cancer Res., May 1, 2003; 63(9): 2164 - 2171.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. K. Sengupta, E. M. Smith, K. Kim, M. J. Murnane, and B. D. Smith
DNA Hypermethylation Near the Transcription Start Site of Collagen {alpha}2(I) Gene Occurs in Both Cancer Cell Lines and Primary Colorectal Cancers
Cancer Res., April 15, 2003; 63(8): 1789 - 1797.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Diergaarde, W. L. van Geloof, G. N.P. van Muijen, F. J. Kok, and E. Kampman
Dietary factors and the occurrence of truncating APC mutations in sporadic colon carcinomas: a Dutch population-based study
Carcinogenesis, February 1, 2003; 24(2): 283 - 290.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.